Disposition of LY333531, a selective protein kinase C beta inhibitor, in the Fischer 344 rat and beagle dog.
1. Studies were conducted in the Fischer 344 rat and beagle dog to determine the disposition of LY333531 and its equipotent active des-methyl metabolite, LY338522, both potent and selective inhibitors of the beta-isozyme of protein kinase C. 2. Male Fischer 344 rats and female beagle dogs received a single 5-mg kg(-1) oral dose of (14)C-LY333531. Urine, faeces, bile and plasma were collected and analysed for (14)C, LY333531 and LY338522. 3. LY333531 was eliminated primarily in the faeces (91% by 120 h in rat, 90% by 96 h in dog). Bile contributed the majority of the radioactivity excreted in the faeces in rat (66% in the cannulated bile duct study) and a variable but significant proportion in dog. 4. Pharmacokinetics following a single 5 mg kg(-1) oral dose of (14)C-LY333531 to the male rat produced C(max) and AUC(0-infinity ) for LY333531 of 14.7 ng ml(-1) and 60.8 ng h ml(-1), respectively, with a half-life of 2.5 h. LY338522 and total radioactivity showed similar profiles. 5. In the female dog at the same dose, C(max) and AUC(0-infinity ) of LY333531 were higher, producing 245 +/- 94 ng ml(-1) and 1419 +/- 463 ng h ml(-1), respectively, with a half-life of 5.7 h. 6. The data indicate that the disposition of LY333531 is similar in rat and dog.
Burkey
J L
JL
Lilly Research Laboratories, Division of Eli Lilly and Co, Lilly Corporate Center, Indianapolis, IN 46285, USA. burkey_jennifer_l@lilly.com
Campanale
K M
KM
O'Bannon
D D
DD
Cramer
J W
JW
Farid
N A
NA
D000818:Animals; D019540:Area Under Curve; D004285:Dogs; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics*; D005260:Female; D007211:Indoles / Q000493:pharmacokinetics*; D008297:Male; D008301:Maleimides / Q000493:pharmacokinetics*; D008956:Models, Chemical; D020033:Protein Isoforms; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D051381:Rats; D011916:Rats, Inbred F344; D013045:Species Specificity; D013997:Time Factors
D004791:Enzyme Inhibitors; D007211:Indoles; C474461:LY 338522; D008301:Maleimides; D020033:Protein Isoforms; C099154:ruboxistaurin; D011493:Protein Kinase C